Festive Sale – 50% Off!

Advertisement
AdvertisementAdvertisement
logo

Vivo Bio Tech

511509
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Vivo Bio Tech Share price and Fundamental Analysis

View All Details
View All Details
Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities.
Company Incorporation1987
ChairmanK Sunder
Head QuartersSecunderabad
Previous NameNA

Key Metrics

Market Cap (Cr)
78.66
PE Ratio
9.31
Industry P/E
32.05
PEG Ratio
0.07
ROE
9.35%
ROCE
12.35%
ROA
5.9%
Total Debt (Cr)
54.03
Debt to Equity
0.69
Dividend Yield
0%
EPS
3.96
Book Value & P/B
41.9 x 0.88
Face Value
10
Outstanding Shares(Cr)
2.13
Current Ratio
4.79
EV to Sales
2.68

Stock Returns

1 Week-0.03%
1 Month0%
6 Months+3.85%
1 Year+2.21%
3 Years+5.26%
5 Years-27.8%
no_data

No Stocks

Smart Score

1.6
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Aug 25

Promoters : 36.43%

FIIs : 0.00%

DIIs : 0.00%

Public : 63.57%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in August 2025 Qtr
Promoter Shareholding Decreased by 4.22% to 36.43% in August 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Vivo Bio Tech Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Vivo Bio Tech Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities.

The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins.

In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists.

The In-vivo Services group at Vivo Bio Tech provides both non-regulatory and regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology, our scientists can provide design & development of xenograft models for evaluation of anti-cancer agents. Further, our scientists can customize in-vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models.

Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents.

Vivo Bio Tech Share Price

Vivo Bio Tech share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Vivo Bio Tech Market Cap

Market capitalization of Vivo Bio Tech indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Vivo Bio Tech is valued compared to its competitors.

Vivo Bio Tech PE Ratio

Vivo Bio Tech PE ratio helps investors understand what is the market value of each stock compared to Vivo Bio Tech 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Vivo Bio Tech PEG Ratio

The PEG ratio of Vivo Bio Tech evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Vivo Bio Tech ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Vivo Bio Tech generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Vivo Bio Tech ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Vivo Bio Tech in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Vivo Bio Tech Total Debt

Total debt of Vivo Bio Tech shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Vivo Bio Tech Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Vivo Bio Tech compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Vivo Bio Tech CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Vivo Bio Tech over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Vivo Bio Tech Technical Analysis

Technical analysis of Vivo Bio Tech helps investors get an insight into when they can enter or exit the stock. Key components of Vivo Bio Tech Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Vivo Bio Tech shares often struggle to rise above due to selling pressure.

Vivo Bio Tech Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Vivo Bio Tech ’s financial health and profitability.

Vivo Bio Tech Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Vivo Bio Tech Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Vivo Bio Tech Financials

The financials of Vivo Bio Tech provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Vivo Bio Tech Profit and Loss Statements

The profit and loss statement of Vivo Bio Tech highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Vivo Bio Tech .

Vivo Bio Tech Balance Sheet

The balance sheet presents a snapshot of Vivo Bio Tech ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Vivo Bio Tech Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.